Synthetic Siglec-9 Agonists Inhibit Neutrophil Activation Associated with COVID-19

Mostrar otras versiones (1)

[Image: see text] Severe cases of coronavirus disease 2019 (COVID-19), caused by infection with SARS-CoV-2, are characterized by a hyperinflammatory immune response that leads to numerous complications. Production of proinflammatory neutrophil extracellular traps (NETs) has been suggested to be a ke...

Descripción completa

Detalles Bibliográficos
Autores principales: Delaveris, Corleone S., Wilk, Aaron J., Riley, Nicholas M., Stark, Jessica C., Yang, Samuel S., Rogers, Angela J., Ranganath, Thanmayi, Nadeau, Kari C., Blish, Catherine A., Bertozzi, Carolyn R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Chemical Society 2021
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8009098/
https://www.ncbi.nlm.nih.gov/pubmed/34056095
http://dx.doi.org/10.1021/acscentsci.0c01669

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8009098/
https://www.ncbi.nlm.nih.gov/pubmed/34056095
http://dx.doi.org/10.1021/acscentsci.0c01669

Ejemplares similares